A previous study demonstrated that knockdown of FAK in carcinoma-associated fibroblasts (CAFs) might suppress OSCC metastasis, and suggested that targeting FAK in CAFs may be a promising strategy for the OSCC treatment [33]. The gene discussed is PTK2; the disease is carcinoma.